Compare PGEN & DAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | DAO |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2013 | 2019 |
| Metric | PGEN | DAO |
|---|---|---|
| Price | $4.12 | $11.28 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 50.4K |
| Earning Date | 05-13-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $230,981,000.00 | N/A |
| Revenue This Year | $1,115.92 | $12.24 |
| Revenue Next Year | $81.04 | $14.60 |
| P/E Ratio | ★ N/A | $72.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.23 | $8.00 |
| 52 Week High | $5.47 | $12.96 |
| Indicator | PGEN | DAO |
|---|---|---|
| Relative Strength Index (RSI) | 54.94 | 58.80 |
| Support Level | $3.91 | $8.92 |
| Resistance Level | $4.31 | $12.96 |
| Average True Range (ATR) | 0.19 | 0.88 |
| MACD | 0.00 | 0.08 |
| Stochastic Oscillator | 64.01 | 66.53 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.